|Bid||880.65 x 0|
|Ask||881.95 x 0|
|Day's range||845.20 - 883.65|
|52-week range||281.15 - 967.60|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||17.33|
|Forward dividend & yield||N/A (N/A)|
|1y target est||762.03|
New Mountain Capital announced that it has reached a definitive agreement with Aurobindo Pharma to acquire Natrol and combine it with Jarrow Formulas, another New Mountain Capital portfolio company. The transaction is expected to close by January 2021 subject to customary closing conditions and regulatory approvals.
The Aurobindo Pharma (NSI:AUROPHARMA) share price has risen by 12.7% over the past month and it’s currently trading at 865.75. For investors considering whethe...
The Aurobindo Pharma (NSI:AUROPHARMA) share price is currently trading at 834.35. But to try and predict what the price will look like in the next 12 months an...